Veterinary and Comparative Oncology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Editorial
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page 1-1, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Source Type: research
---
Veterinary and Comparative Oncology,Volume 16, Issue 1, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Source Type: research
---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page i-i, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Source Type: research
---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page 1-1, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Source Type: research
Editorial
(Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Authors: D. H. Thamm Tags: EDITORIAL Source Type: research
Issue Information
(Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Tags: ISSUE INFORMATION Source Type: research
Cover Image, Volume 16, Issue 1
The cover image, by Alexandra Keller et al., is based on the Original Article The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma, DOI: 10.1111/vco.12311
The cover image, by Alexandra Keller et al., is based on the Original Article The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma, DOI: 10.1111/vco.12311 (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 21, 2018 Category: Veterinary Research Authors: Alexandra Keller, Bettina Wingelhofer, Barbara Peter, Karin Bauer, Daniela Berger, Susanne Gamperl, Martin Reifinger, Sabine Cerny ‐Reiterer, Richard Moriggl, Michael Willmann, Peter Valent, Emir Hadzijusufovic Tags: COVER IMAGE Source Type: research
Engineering controls in veterinary oncology: A survey of 148 ACVIM board ‐certified oncologists and environmental surveillance in 20 specialty hospitals
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 15, 2018 Category: Veterinary Research Source Type: research
---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - February 15, 2018 Category: Veterinary Research Source Type: research
Checkpoint molecule expression by B and T cell lymphomas in dogs
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 30, 2018 Category: Veterinary Research Source Type: research
Evaluation of a multi ‐agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non‐Hodgkin high‐grade lymphomas
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 30, 2018 Category: Veterinary Research Source Type: research
---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 30, 2018 Category: Veterinary Research Source Type: research
Evaluation of a multi ‐agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non‐Hodgkin high‐grade lymphomas
The standard of care treatment for canine lymphoma is multi‐agent chemotherapy containing prednisolone, cyclophosphamide, vincristine and an anthracycline such as doxorubicin (CHOP) or epirubicin (CEOP). Lomustine, vincristine, procarbazine, and prednisone (LOPP) has been evaluated as a rescue, with encouraging results; however, resistance to vincristine is likely in patients relapsing on CHOP/CEOP, and this agent may enhance LOPP toxicity without improving efficacy. The aim of this study was to evaluate responses to a modified‐LOPP protocol that does not include vincristine (LPP) and is administered on a 21‐day cycl...
Source: Veterinary and Comparative Oncology - January 30, 2018 Category: Veterinary Research Authors: J. ‐B. Tanis, S. L. Mason, T. W. Maddox, L. Blackwood, D. R. Killick, I. Amores‐Fuster, A. Harper, R. Finotello Tags: ORIGINAL ARTICLE Source Type: research
Canine spinal meningiomas and nerve sheath tumours in 34 dogs (2008 ‐2016): Distribution and long‐term outcome based upon histopathology and treatment modality
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - January 23, 2018 Category: Veterinary Research Source Type: research
